Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Anti-ischemic effects of atenolol versus nifedipine in patients with coronary artery disease and ambulatory silent ischemia.

Deedwania PC, Carbajal EV, Nelson JR, Hait H.

J Am Coll Cardiol. 1991 Mar 15;17(4):963-9.

PMID:
1999634
2.

Effects of atenolol alone, nifedipine alone and their combination on ambulant myocardial ischemia.

Hill JA, Gonzalez JI, Kolb R, Pepine CJ.

Am J Cardiol. 1991 Apr 1;67(8):671-5.

PMID:
2006616
3.

Effect of nifedipine on total ischemic activity and circadian distribution of myocardial ischemic episodes in angina pectoris.

Nesto RW, Phillips RT, Kett KG, McAuliffe LS, Roberts M, Hegarty P.

Am J Cardiol. 1991 Jan 15;67(2):128-32.

PMID:
1987713
5.

Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.

Stone PH, Gibson RS, Glasser SP, DeWood MA, Parker JD, Kawanishi DT, Crawford MH, Messineo FC, Shook TL, Raby K, et al.

Circulation. 1990 Dec;82(6):1962-72.

PMID:
2122926
6.

Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS)

Andrews TC, Fenton T, Toyosaki N, Glasser SP, Young PM, MacCallum G, Gibson RS, Shook TL, Stone PH.

Circulation. 1993 Jul;88(1):92-100.

PMID:
8319361
7.

Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)

Pepine CJ, Cohn PF, Deedwania PC, Gibson RS, Handberg E, Hill JA, Miller E, Marks RG, Thadani U.

Circulation. 1994 Aug;90(2):762-8.

PMID:
8044945
8.

Morning increase in ambulatory ischemia in patients with stable coronary artery disease. Importance of physical activity and increased cardiac demand.

Parker JD, Testa MA, Jimenez AH, Tofler GH, Muller JE, Parker JO, Stone PH.

Circulation. 1994 Feb;89(2):604-14.

PMID:
8313548
9.
10.
11.

The efficacy of the addition of nifedipine in patients with mixed angina compared to patients with classic exertional angina: a multicenter, randomized, double-blind, placebo-controlled clinical trial.

Stone PH, Ware JH, DeWood MA, Gore JM, Eich RH, Pietro DA, Parisi AF, Nesto RW, Boden WE, Sharma SC, et al.

Am Heart J. 1988 Oct;116(4):961-71.

PMID:
2902779
14.

Attenuation of the circadian patterns of myocardial ischemia with nifedipine GITS in patients with chronic stable angina. N-CAP Study Group.

Parmley WW, Nesto RW, Singh BN, Deanfield J, Gottlieb SO.

J Am Coll Cardiol. 1992 Jun;19(7):1380-9.

PMID:
1350596
15.

Transient myocardial ischemia during daily life in rest and exertional angina pectoris and comparison of effectiveness of metoprolol versus nifedipine.

Ardissino D, Savonitto S, Egstrup K, Marraccini P, Slavich G, Rosenfeld M, Feruglio GA, Roncarolo P, Giordano MP, Wahlqvist I, et al.

Am J Cardiol. 1991 May 1;67(11):946-52.

PMID:
2018012
16.
18.

Effects of theophylline, atenolol and their combination on myocardial ischemia in stable angina pectoris.

Crea F, Pupita G, Galassi AR, el-Tamimi H, Kaski JC, Davies GJ, Maseri A.

Am J Cardiol. 1990 Nov 15;66(17):1157-62.

PMID:
2239717
20.

Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.

Di Somma S, de Divitiis M, Bertocchi F, Carotenuto A, Cudemo G, Petitto M, Napodano M, de Divitiis O.

Cardiologia. 1996 Jul;41(7):635-43.

PMID:
8831181

Supplemental Content

Support Center